Vascular and Endovascular Surgery

Publisher: SAGE Publications Inc.
Country: United States · Northern America
Type: journal
ISSN: 15385744

19389116

Scopus 0,286 SJR

Scopus Q3 SJR Q

WoS Q4 JCR Q

WoS 0,7 JIF

Scopus 59 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

SJR 0,286
Quartile Q3
H-Index 59
Cites/doc 0,9
Docs (3y) 419
Cites (3y) 341

Clarivate

Web of Science · JCR · 2025

JCR Q Q4
JIF 0,7
5Y JIF 0,8
JCI 0,22

WoS indexes

SCIE

Subject classification

Categories (SJR)

Cardiology and Cardiovascular Medicine Q3
Medicine (miscellaneous) Q3
Surgery Q3

Areas

Medicine

WoS categories

Surgery | Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year	SJR Q	JCR Q (1997+)	SJR	JIF (1997+)	5Y JIF (1997+)	JCI (1997+)	JCI Q (1997+)	H-Index
2025	Q3	Q4	0,286	0,7	0,8	0,22	Q4	59
2024	Q3	Q4	0,356	0,7	0,9	0,25	Q4	56
2023	Q3	Q4	0,348	0,7	0,9	0,24	Q4	56
2022	Q2	Q4	0,448	0,9	1	0,27	Q4	56
2021	Q2	Q4	0,43	1	1,2	0,29	Q4	56
2020	Q2	Q4	0,46	1,1	1,2	0,3	Q4	56
2019	Q3	Q4	0,439	0,9	1,1	0,3	Q4	56
2018	—	Q4	—	0,9	1	0,28	Q4	—
2017	Q2	Q4	0,528	0,9	1	0,34	Q3	56
2016	Q2	Q3	0,511	1,1	1	—	—	56
2015	Q2	Q4	0,432	0,8	0,9	—	—	56
2014	Q2	Q4	0,502	0,7	1	—	—	56
2013	Q2	Q4	0,636	0,8	1	—	—	56
2012	Q2	Q3	0,527	0,9	—	—	—	56
2011	Q2	Q3	0,599	1	—	—	—	56
2010	Q2	Q3	0,64	1,2	—	—	—	56

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year	Category	Edition	JCR Q (1997+)	JCI Q (1997+)	Rank
2025	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q4	89/100
2025	SURGERY	SCIE	Q4	Q4	268/321
2024	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q4	89/98
2024	SURGERY	SCIE	Q4	Q4	250/314
2023	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q4	85/96
2023	SURGERY	SCIE	Q4	Q4	231/292
2022	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q4	67/68
2022	SURGERY	SCIE	Q4	Q4	187/213
2021	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q4	66/67
2021	SURGERY	SCIE	Q4	Q4	189/213
2020	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q4	63/65
2020	SURGERY	SCIE	Q4	Q4	187/211
2019	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q4	64/65
2019	SURGERY	SCIE	Q4	Q4	185/210
2018	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q4	65/65
2018	SURGERY	SCIE	Q4	Q4	176/203
2017	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	Q4	65/65
2017	SURGERY	SCIE	Q4	Q3	167/200
2016	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	—	61/63
2016	SURGERY	SCIE	Q3	—	147/197
2015	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	—	61/63
2015	SURGERY	SCIE	Q4	—	158/200
2014	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	—	60/60
2014	SURGERY	SCIE	Q4	—	167/198
2013	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	—	61/65
2013	SURGERY	SCIE	Q4	—	159/204
2012	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	—	59/68
2012	SURGERY	SCIE	Q3	—	135/199
2011	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	—	58/68
2011	SURGERY	SCIE	Q3	—	133/199
2010	PERIPHERAL VASCULAR DISEASE	SCIE	Q4	—	53/68
2010	SURGERY	SCIE	Q3	—	102/188